OPRM1 rs2075572 has potential to affect plasma buprenorphine level in opioid users, but not OPRM1 rs562859

This publication has 51 references indexed in Scilit:

• Pharmacogenetics of Opioid Use Disorder Treatment
  CNS Drugs, 2018
• The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C Polymorphisms of OPRM1 Gene is Associated with Sleep Quality Among Opioid-Dependent Patients on Methadone Maintenance Therapy
  Pain and Therapy, 2016
• The Opposing Roles of IVS2+691 CC Genotype and AC/AG Diplotype of 118A>G and IVS2+691G>C of OPRM1 Polymorphisms in Cold Pain Tolerance Among Opioid-Dependent Malay Males on Methadone Therapy
  Pain and Therapy, 2015
• A Population Pharmacokinetic and Pharmacodynamic Modelling Approach to Support the Clinical Development of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Dependence
  Clinical Pharmacokinetics, 2014
• Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P
  Synapse, 2013
• Opioid Receptor Polymorphism A118G Associated with Clinical Severity in a Drug Overdose Population
  Journal of Medical Toxicology, 2013
• Novel exonic μ‐opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence
  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2004
• Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene Oprm
  Synapse, 2003
• Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin
  Human Mutation, 2002
• The human µ opioid receptor gene: 5´ regulatory and intronic sequences
  Journal of Molecular Medicine, 1998